This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,537.17 contract is for the supply of Quillivant XR, a 25 mg/5 ml suspension, with a period of performance through December 18, 2024. DMS Pharmaceutical Group is a key supplier to the Department of Defense (DoD), providing a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military healthcare facilities through its federal contract awards. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to place orders for various pharmaceutical products to support the medical supply needs of DoD healthcare sites worldwide.
Generated 3/23/25, 1:01 AM